{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:24:17Z","timestamp":1791822257005,"version":"4.3.4"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"vor","delay-in-days":821,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Antibiotic resistance has increasingly been recognized as the major cause of treatment failure for <jats:italic>Helicobacter pylori<\/jats:italic> infection. New therapies for patients with metronidazole\u2010 or clarithromycin\u2010resistant <jats:italic>H. pylori<\/jats:italic> are needed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To investigate the role of nitrofurantoin quadruple therapy for the treatment of <jats:italic>H. pylori<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Patients with confirmed <jats:italic>H. pylori<\/jats:italic> infection received nitrofurantoin (100\u2003mg t.d.s.), omeprazole (20\u2003mg b.d.), Pepto\u2010Bismol (two tablets t.d.s.), and tetracycline (500\u2003mg t.d.s.) for 14\u2003days. Four or more weeks after the end of therapy, outcome was assessed by repeat endoscopy with histology and culture or urea breath testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Thirty patients were entered, including 25 men and five women; the mean age was 54.9\u2003years. The most common diagnoses were duodenal ulcer (23%) and GERD (18%). The intention\u2010to\u2010treat cure rate was 70% (95% CI: 50.6\u201385%). Nitrofurantoin quadruple therapy was more effective with metronidazole\u2010sensitive strains (88%; 15 out of 17) than with metronidazole\u2010resistant strains (33%; three out of nine; <jats:italic>P<\/jats:italic>=0.008). Two of the treatment failures had pre\u2010treatment isolates susceptible to metronidazole, which were resistant after therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Because nitrofurantoin quadruple therapy performed inadequately in the presence of metronidazole resistance, we conclude that nitrofurantoin is unlikely to find clinical utility for the eradication of <jats:italic>H. pylori<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.00945.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:44:03Z","timestamp":1047354243000},"page":"513-518","source":"Crossref","is-referenced-by-count":10,"title":["Nitrofurantoin quadruple therapy for <i>Helicobacter pylori<\/i> infection: effect of metronidazole resistance"],"prefix":"10.1111","volume":"15","author":[{"given":"D. Y.","family":"Graham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M. T.","family":"El\u2010Zimaity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. H.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Osato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0303.970320"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/87.1.49"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091727"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809096287"},{"key":"e_1_2_6_6_2","first-page":"1158","article-title":"Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuth subsalicylate and nitrofurantoin","volume":"86","author":"Graham DY","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","unstructured":"B\u00f6rschGM&GrahamDY.Helicobacter pylori. In: Collen MJ Benjamin SB eds. Pharmacology of Peptic Ulcer Disease Handbook of Experimental Pharmacology Vol. 99. Berlin: Springer\u2010Verlag 1991: 107\u201348.","DOI":"10.1007\/978-3-642-75858-4_5"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(98)00302-2"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.suppl_A.23"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0001-706X(94)90062-0"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90348-4"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00640.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00709.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00172.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90303-9"},{"key":"e_1_2_6_16_2","first-page":"1962","article-title":"Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test","volume":"90","author":"El\u2010Zimaity HM","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90191-0"},{"key":"e_1_2_6_18_2","first-page":"732","article-title":"A new triple stain for Helicobacter pylori suitable for the autostainer: carbol fuchsin\/Alcian blue\/hematoxylin\u2010eosin","volume":"122","author":"El\u2010Zimaity HM","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00219.x"},{"key":"e_1_2_6_20_2","first-page":"641","article-title":"Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens","volume":"8","author":"De Boer WA","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-4825(96)00006-6"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1086\/514640"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/514641"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2133-2142.2000"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.306-308.2001"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.1.9"},{"key":"e_1_2_6_27_2","first-page":"165","article-title":"Mode of action of metronidazole on anaerobic bacteria and protozoa","volume":"93","author":"Muller M","year":"1983","journal-title":"Surgery"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-100-2-283"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00945.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00945.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.00945.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:33:33Z","timestamp":1697506413000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.00945.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1046\/j.1365-2036.2001.00945.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.00945.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}